Ocrelizumab for Psychosis by Autoimmunity
Clinical trial NCT03971487 · RECRUITING
Trial details
- NCT number
- NCT03971487
- Sponsor
- The Methodist Hospital Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2028-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.